Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors (Q38406496)
Jump to navigation
Jump to search
scientific article published on 12 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors |
scientific article published on 12 December 2011 |
Statements
1 reference
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors (English)
1 reference
Jaap Verweij
1 reference
Johanna C Bendell
1 reference
Jordi Rodon
1 reference
Howard A Burris
1 reference
Maja de Jonge
1 reference
Diana Birle
1 reference
David Demanse
1 reference
Stefan S De Buck
1 reference
Qinhua C Ru
1 reference
Malte Peters
1 reference
Michael Goldbrunner
1 reference
José Baselga
1 reference
12 December 2011
1 reference
1 reference
Identifiers
1 reference